BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Tables)

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2020

Summary of Opening and Closing Balances of Contract Liabilities

The Company performs its obligations under a contract with a customer by transferring products and/or services in exchange for consideration from the customer. The Company typically invoices its customers as soon as control of an asset is transferred and a receivable for the Company is established. The Company, however, recognizes a contract liability when a customer prepays for goods and/or services and the Company has not transferred control of the goods and/or services. The opening and closing balances of the Company’s contract liabilities are as follows (in thousands):

	March 31,		December 31,
	2020		2019
Undelivered elements (training, installation, product and support services)	$	476	$	559
Extended warranty contracts		1,896		2,063
Total deferred revenue		2,372		2,622
Less long-term portion of deferred revenue		390		385
Total deferred revenue — long -term		390		385
Deferred revenue — current	$	1,982	$	2,237

Summary of Disaggregation of Revenues Related to Geographic Areas

The Company’s revenues related to the following geographic areas were as follows for the periods indicated (in thousands):

	Three Months Ended
	March 31,
	2020		2019
United States	$	3,129	$	6,116
International		1,654		4,210
	$	4,783	$	10,326

Summary of Revenues Disaggregated by Timing of Goods and Services Transferred

Information regarding revenues disaggregated by the timing of when goods and services are transferred is as follows (in thousands):

	Three Months Ended
	March 31,
	2020		2019
Revenue recognized over time	$	1,260	$	1,698
Revenue recognized at a point in time		3,523		8,628
Total	$	4,783	$	10,326

Summary of Sales by End Market

The Company’s sales by end market were as follows for the periods indicated (in thousands):

	Three Months Ended
	March 31,
	2020		2019
End-customer	$	2,340	$	6,346
Distributors		2,443		3,980
	$	4,783	$	10,326

Schedule of Revenue and Percentages of Revenue Sales by Product Line

The revenue and percentages of revenue of the Company’s sales by product line were as follows for the periods indicated:

	Three Months Ended
	March 31,
	2020				2019
Laser systems	$	2,051	42.9	%	$	5,964	57.8	%
Imaging systems		—	—	%		552	5.3	%
Consumables and other		1,472	30.8	%		2,112	20.5	%
Services		1,260	26.3	%		1,695	16.4	%
License fees and royalties		—	—	%		3	—	%
Total revenue	$	4,783	100.0	%	$	10,326	100.0	%

Revenue from the Company’s products for the three months ended March 31, 2020 and 2019 are as follows (dollars in thousands):

	Three Months Ended
	March 31,
	2020				2019
Laser systems	$	2,051	42.9	%	$	5,964	57.8	%
Imaging systems		—	—	%		552	5.3	%
Consumables and other		1,472	30.8	%		2,112	20.5	%
Services		1,260	26.3	%		1,695	16.4	%
License fees and royalties		—	—	%		3	—	%
Total revenue	$	4,783	100.0	%	$	10,326	100.0	%